Pathophysiological roles of extracellular nucleotides in glial cells: differential expression of purinergic receptors in resting and activated microglia - PubMed (original) (raw)

Comparative Study

Pathophysiological roles of extracellular nucleotides in glial cells: differential expression of purinergic receptors in resting and activated microglia

Fabio Bianco et al. Brain Res Brain Res Rev. 2005 Apr.

Abstract

Microglial cells are the major cellular elements with immune function inside the CNS and play important roles in orchestrating inflammatory brain response to hypoxia and trauma. Although a complete knowledge of the endogenous factors leading to a prompt activation of microglia is not yet available, activation of P2 purinoreceptors by extracellular ATP has been indicated as a primary factor in microglial response. A still unresolved question, however, is which subtype(s) of P2 receptors mediate(s) the response to ATP. By a combination of RT-PCR, Western blotting, and single-cell calcium imaging, we assessed the presence and the activity of P2 receptor subtypes in the mouse microglial cell line N9. All members of the P2 receptor family, including the recently reported receptor for sugar nucleotides (P2Y(14)), were found to be present in these cells at mRNA and/or protein level. The functionality of the receptors was assessed by analysis of the calcium responses evoked by specific agonists both in N9 cells and in primary microglia from rat brain. Interestingly, a different functional profile of P2 receptors was observed in resting or in LPS-activated N9 cells. Overnight exposure to LPS increased P2Y(6) and P2Y(14), decreased P2X(7), and left unchanged P2Y(1) and P2Y(2,4) receptor activity. The change in the P2 receptor profile in activated cells suggests selective roles for specific P2 receptor subtypes in microglial activation triggered by LPS. We speculate that modulation of microglial cell function via subtype-selective P2 receptor ligands may open up new strategies in the therapeutic management of inflammatory neurological diseases characterized by abnormal microglia response.

PubMed Disclaimer

Cited by

Quantification of extracellular UDP-galactose.
Lazarowski ER. Lazarowski ER. Anal Biochem. 2010 Jan 1;396(1):23-9. doi: 10.1016/j.ab.2009.08.022. Epub 2009 Aug 21. Anal Biochem. 2010. PMID: 19699703 Free PMC article.
Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics - An AI-Enabled Biological Target Discovery Platform.
Pun FW, Liu BHM, Long X, Leung HW, Leung GHD, Mewborne QT, Gao J, Shneyderman A, Ozerov IV, Wang J, Ren F, Aliper A, Bischof E, Izumchenko E, Guan X, Zhang K, Lu B, Rothstein JD, Cudkowicz ME, Zhavoronkov A. Pun FW, et al. Front Aging Neurosci. 2022 Jun 28;14:914017. doi: 10.3389/fnagi.2022.914017. eCollection 2022. Front Aging Neurosci. 2022. PMID: 35837482 Free PMC article.
Integration of P2Y receptor-activated signal transduction pathways in G protein-dependent signalling networks.
Van Kolen K, Slegers H. Van Kolen K, et al. Purinergic Signal. 2006 Sep;2(3):451-69. doi: 10.1007/s11302-006-9008-0. Epub 2006 Jun 7. Purinergic Signal. 2006. PMID: 18404483 Free PMC article.
Targeting Neuroinflammation via Purinergic P2 Receptors for Disease Modification in Drug-Refractory Epilepsy.
Engel T, Smith J, Alves M. Engel T, et al. J Inflamm Res. 2021 Jul 18;14:3367-3392. doi: 10.2147/JIR.S287740. eCollection 2021. J Inflamm Res. 2021. PMID: 34305404 Free PMC article. Review.
Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection.
Witting A, Chen L, Cudaback E, Straiker A, Walter L, Rickman B, Möller T, Brosnan C, Stella N. Witting A, et al. Proc Natl Acad Sci U S A. 2006 Apr 18;103(16):6362-7. doi: 10.1073/pnas.0510418103. Epub 2006 Mar 29. Proc Natl Acad Sci U S A. 2006. PMID: 16571660 Free PMC article.

Pathophysiological roles of extracellular nucleotides in glial cells: differential expression of purinergic receptors in resting and activated microglia - PubMed (original) (raw)